SG Americas Securities
TAK icon

SG Americas Securities’s Takeda Pharmaceutical TAK Stock Holding History

SG Americas Securities’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$113K Hold
7,065
– – ﹤0.01% 3064
2026
Q1 		$131K Sell
7,065
-6,791
-49% -$119K ﹤0.01% 2830
2025
Q4 		$216K Buy
13,856
+6,222
+82% +$89K ﹤0.01% 2896
2025
Q3 		$112K Buy
+7,634
New +$113K ﹤0.01% 3036
2025
Q2 		– Sell
-7,158
Closed -$106K – 3573
2025
Q1 		$106K Buy
+7,158
New +$100K ﹤0.01% 3005
2024
Q2 		– Sell
-16,099
Closed -$224K – 3295
2024
Q1 		$224K Buy
16,099
+824
+5% +$12K ﹤0.01% 1888
2023
Q4 		$218K Sell
15,275
-768
-5% -$10.9K ﹤0.01% 2087
2023
Q3 		$248K Buy
16,043
+6,775
+73% +$105K ﹤0.01% 2181
2023
Q2 		$146K Hold
9,268
– – ﹤0.01% 1928
2023
Q1 		$153K Buy
+9,268
New +$148K ﹤0.01% 2625
2022
Q2 		– Sell
-9,729
Closed -$139K – 3604
2022
Q1 		$139K Sell
9,729
-14,701
-60% -$216K ﹤0.01% 2632
2021
Q4 		$333K Hold
24,430
– – ﹤0.01% 2389
2021
Q3 		$400K Sell
24,430
-39
-0.2% -$655 ﹤0.01% 2701
2021
Q2 		$412K Sell
24,469
-8,914
-27% -$152K ﹤0.01% 2029
2021
Q1 		$610K Buy
33,383
+8,915
+36% +$160K ﹤0.01% 1875
2020
Q4 		$445K Hold
24,468
– – ﹤0.01% 2060
2020
Q3 		$437K Sell
24,468
-4
-0% -$73 ﹤0.01% 1722
2020
Q2 		$439K Buy
24,472
+200
+0.8% +$3.59K ﹤0.01% 2204
2020
Q1 		$368K Sell
24,272
-25
-0.1% -$453 ﹤0.01% 2076
2019
Q4 		$479K Buy
24,297
+4
+0% +$77 ﹤0.01% 1829
2019
Q3 		$418K Buy
24,293
+146
+0.6% +$2.52K ﹤0.01% 1992
2019
Q2 		$427K Buy
24,147
+1,785
+8% +$32.5K ﹤0.01% 1982
2019
Q1 		$456K Buy
+22,362
New +$450K ﹤0.01% 1924

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

SG Americas Securities's TAK Position: Q2 2026 in Review

SG Americas Securities held its Takeda Pharmaceutical (TAK) position steady in Q2 2026 at 7,065 shares worth $113K. The position accounts for ﹤0.01% of the portfolio, ranked #3064.

SG Americas Securities first reported a position in TAK in Q1 2019 and has held it in 23 quarters since. The position peaked at $610K in Q1 2021. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • SG Americas Securities held 7,065 shares of Takeda Pharmaceutical worth $113K as of Q2 2026.
  • SG Americas Securities left its Takeda Pharmaceutical share count unchanged in Q2 2026.
  • Takeda Pharmaceutical made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #3064 holding.
  • SG Americas Securities first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 23 quarters since.
  • SG Americas Securities's Takeda Pharmaceutical position peaked at $610K in Q1 2021.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.